ATC Group: C09BX03 Ramipril, amlodipine and hydrochlorothiazide

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of C09BX03 in the ATC hierarchy

Level Code Title
1 C Cardiovascular system
2 C09 Agents acting on the renin-angiotensin system
3 C09B ACE inhibitors, combinations
4 C09BX ACE inhibitors, other combinations
5 C09BX03

Active ingredients in C09BX03

Active Ingredient Description
Ramipril, Amlodipine and Hydrochlorothiazide

Ramiprilat, the active metabolite of the prodrug ramipril, inhibits the enzyme dipeptidylcarboxypeptidase I. Decreased formation of angiotensin II and inhibition of bradykinin degradation lead to vasodilation. Amlodipine is a calcium ion influx inhibitor of the dihydropyridine group and inhibits the entry of calcium ions through the cell membrane into cardiac cells and smooth muscle fibers. Hydrochlorothiazide is a thiazide diuretic. The mechanism of antihypertensive action of thiazide diuretics is not fully understood.

Medicines in this ATC group

Croatia (HR)

Estonia (EE)

Poland (PL)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.